The Cellular and Gene Therapies Facility consists of a pharmaceutical plant authorized to produce cell therapy drugs, which, along with gene therapy drugs and tissue engineering products, are referred to as Advanced Therapy Medicinal Products (ATMPs).
The focus of research is the development of advanced therapies as innovative treatment tools for serious diseases for which conventional treatments have proven ineffective or nonexistent.
Updated at 11:29
of 17/07/2025